Matches in Wikidata for { <http://www.wikidata.org/entity/Q60757295> ?p ?o ?g. }
Showing items 1 to 36 of
36
with 100 items per page.
- Q60757295 description "ensayu clínicu" @default.
- Q60757295 description "klinisch onderzoek" @default.
- Q60757295 description "klinisk undersøgelse" @default.
- Q60757295 name "SHORT-HER: MULTICENTRIC RANDOMISED PHASE III TRIAL OF ADJUVANT CHEMOTHERAPY PLUS 3 VS 12 MONTHS OF TRASTUZUMAB IN BREAST CANCER PATIENTS WITH HER2 POSITIVE DISEASE" @default.
- Q60757295 name "SHORT-HER: MULTICENTRIC RANDOMISED PHASE III TRIAL OF ADJUVANT CHEMOTHERAPY PLUS 3 VS 12 MONTHS OF TRASTUZUMAB IN BREAST CANCER PATIENTS WITH HER2 POSITIVE DISEASE" @default.
- Q60757295 name "SHORT-HER: MULTICENTRIC RANDOMISED PHASE III TRIAL OF ADJUVANT CHEMOTHERAPY PLUS 3 VS 12 MONTHS OF TRASTUZUMAB IN BREAST CANCER PATIENTS WITH HER2 POSITIVE DISEASE" @default.
- Q60757295 type Item @default.
- Q60757295 label "SHORT-HER: MULTICENTRIC RANDOMISED PHASE III TRIAL OF ADJUVANT CHEMOTHERAPY PLUS 3 VS 12 MONTHS OF TRASTUZUMAB IN BREAST CANCER PATIENTS WITH HER2 POSITIVE DISEASE" @default.
- Q60757295 label "SHORT-HER: MULTICENTRIC RANDOMISED PHASE III TRIAL OF ADJUVANT CHEMOTHERAPY PLUS 3 VS 12 MONTHS OF TRASTUZUMAB IN BREAST CANCER PATIENTS WITH HER2 POSITIVE DISEASE" @default.
- Q60757295 label "SHORT-HER: MULTICENTRIC RANDOMISED PHASE III TRIAL OF ADJUVANT CHEMOTHERAPY PLUS 3 VS 12 MONTHS OF TRASTUZUMAB IN BREAST CANCER PATIENTS WITH HER2 POSITIVE DISEASE" @default.
- Q60757295 altLabel "shorther" @default.
- Q60757295 prefLabel "SHORT-HER: MULTICENTRIC RANDOMISED PHASE III TRIAL OF ADJUVANT CHEMOTHERAPY PLUS 3 VS 12 MONTHS OF TRASTUZUMAB IN BREAST CANCER PATIENTS WITH HER2 POSITIVE DISEASE" @default.
- Q60757295 prefLabel "SHORT-HER: MULTICENTRIC RANDOMISED PHASE III TRIAL OF ADJUVANT CHEMOTHERAPY PLUS 3 VS 12 MONTHS OF TRASTUZUMAB IN BREAST CANCER PATIENTS WITH HER2 POSITIVE DISEASE" @default.
- Q60757295 prefLabel "SHORT-HER: MULTICENTRIC RANDOMISED PHASE III TRIAL OF ADJUVANT CHEMOTHERAPY PLUS 3 VS 12 MONTHS OF TRASTUZUMAB IN BREAST CANCER PATIENTS WITH HER2 POSITIVE DISEASE" @default.
- Q60757295 P1050 Q60757295-d6fdc796-4f1f-50c3-b942-20dc90f194b6 @default.
- Q60757295 P1132 Q60757295-c8930a02-4a17-a3a3-2d67-411c5dc3a534 @default.
- Q60757295 P1476 Q60757295-3584a655-42f8-9c7b-d285-c9bc212e91c5 @default.
- Q60757295 P17 Q60757295-c6d89a13-411d-750e-4510-161966afae96 @default.
- Q60757295 P1813 Q60757295-69739437-4a0d-cf66-157c-31197edef1d2 @default.
- Q60757295 P31 Q60757295-24a9516c-44c0-03a5-f6c2-9d9e44b0efcf @default.
- Q60757295 P4844 Q60757295-9d88778c-475f-7da2-0474-67c7380268f2 @default.
- Q60757295 P6099 Q60757295-9164ab62-48c8-8ce4-9be9-197316a7a890 @default.
- Q60757295 P921 Q60757295-26ed699a-4b67-04e8-ff52-df3833b28a10 @default.
- Q60757295 P921 Q60757295-d8eb4b37-4dcc-9a80-3189-d7ae97f73a93 @default.
- Q60757295 P921 Q60757295-f5b8eb17-4e48-0338-217b-6c10bd65587b @default.
- Q60757295 P1050 Q128581 @default.
- Q60757295 P1132 "+2500" @default.
- Q60757295 P1476 "SHORT-HER: MULTICENTRIC RANDOMISED PHASE III TRIAL OF ADJUVANT CHEMOTHERAPY PLUS 3 VS 12 MONTHS OF TRASTUZUMAB IN BREAST CANCER PATIENTS WITH HER2 POSITIVE DISEASE" @default.
- Q60757295 P17 Q38 @default.
- Q60757295 P1813 "Shother" @default.
- Q60757295 P31 Q30612 @default.
- Q60757295 P4844 Q412616 @default.
- Q60757295 P6099 Q42824827 @default.
- Q60757295 P921 Q128581 @default.
- Q60757295 P921 Q412616 @default.
- Q60757295 P921 Q974135 @default.